Independent fund research. Built on SEC filings.

How we research funds

ETF · Large Blend · SEI

Cultivar ETF (CVAR)

Ticker CVAR · Since 2021-12-22 · · Holdings as of Jul 31, 2026

Expense ratio
0.87%$87/yr per $10k
1-yr return
+3.1%as of Dec 2024
Net assets
$42.9Mall share classes
Holdings
90

Bottom line

Is CVAR a good fund? The bottom line

CVAR is a managed large blend ETF from SEI.

Annual fees run 0.87% — about $87 a year on every $10,000 invested, more expensive than 53% of large blend funds we track.

It returned +3.1% over one year (as of Dec 31, 2024, per its prospectus).

With $42.9 million in net assets and 90 holdings, its largest position is United States of America (5.5%) and the top 10 make up 28.5% of the portfolio.

What to watch

  • Small fund ($42.9 million) — small funds are likelier to close

Updated Nov 19, 2026

What CVAR invests in

The Cultivar ETF (the Fund) seeks long-term capital appreciation.

The Fund is an actively managed exchange traded fund (ETF) that seeks to build a portfolio of approximately 50 to 100 securities across a broad spectrum of market capitalizations and sectors. The Fund may at times take larger positions (greater than 5%) in certain holdings and/or sectors when its research and valuation models indicate that such investments are appropriate. As a result, the Fund will operate as a non-diversified fund, which means it can invest in fewer securities at any one time than a diversified fund. To achieve its investment objective, the Fund invests primarily in equity securities traded on U.S. exchanges of any size that the Funds investment adviser, Cultivar Capital, Inc. (the Adviser), believes are under-valued, or under-appreciated, by other participants in the broader equity market. In selecting securities for the Fund, the Adviser screens on an ongoing basis…

From the fund's prospectus (filed Nov 26, 2025).

CVAR performance

Fund calendar-year total returns, 2022–2024 2022: −4.8%; 2023: +11.8%; 2024: +3.1% −4.8% 2022 +11.8% 2023 +3.1% 2024
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
CVAR+3.1%——
Large Blend median+13.8%+9.7%+10.9%

Source: Fund prospectus, as of Dec 31, 2024

Full CVAR performance history →

What CVAR costs

On a $10,000 investment, CVAR's 0.87% expense ratio costs about $87 a year. The prospectus estimates $1,073 in total costs over 10 years (assuming 5% annual returns). The median large blend fund charges 0.83%.

See the full CVAR fee table →

CVAR top 10 holdings

#Holding% of fund
1United States of America5.51%
2Marketaxess Holdings Inc.4.25%
3United States of America3.45%
4Healthcare Services Group, Inc.2.61%
5United States of America2.54%
6Kimberly-clark Corporation2.29%
7Alexandria Real Estate Equities, Inc.2.12%
8Core Laboratories Inc.2.02%
9Illumina, Inc.1.86%
10Dollar General Corporation1.83%

Source: SEC Form N-PORT, period ended Jul 31, 2026

The top 10 make up 28.5% of the fund. See all top 25 holdings and asset mix →

Alternatives to CVAR

More funds like CVAR →

CVAR FAQ

What is the expense ratio of CVAR?
CVAR's expense ratio is 0.87%, which works out to about $87 a year for every $10,000 invested. The prospectus estimates total costs of $1,073 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is CVAR a good investment?
It depends on your goals, but the data points to: small fund ($42.9 million) — small funds are likelier to close. This is general information, not personalized advice.
What does CVAR hold?
CVAR's largest holdings are United States of America (5.5%), Marketaxess Holdings Inc. (4.2%), United States of America (3.5%), Healthcare Services Group, Inc. (2.6%), United States of America (2.5%). It holds 90 positions in total as of Jul 31, 2026 (SEC Form N-PORT).
Who manages CVAR?
CVAR is offered by SEI through ETF Opportunities Trust.